首页> 外文期刊>The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation >Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts
【24h】

Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts

机译:磷酸化的S6激酶和S6核糖体蛋白是心脏移植物中抗体介导的排斥反应的诊断标志物

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Anti-MHC Class I alloantibodies have been implicated in the processes of acute and chronic rejection. These antibodies (Ab) bind to endothelial cells (EC) and transduce signals leading to the activation of cell survival and proliferation pathways, including Src, FAK and mTOR, as well as downstream targets ERK, S6 kinase (S6K) and S6 ribosomal protein (S6RP). We tested the hypothesis that phosphorylation of S6K, S6RP and ERK in capillary endothelium may serve as an adjunct diagnostic tool for antibody-mediated rejection (AMR) in heart allografts.
机译:背景:抗MHC I类同种抗体已被认为与急性和慢性排斥反应有关。这些抗体(Ab)与内皮细胞(EC)结合并转导信号,导致激活细胞存活和增殖途径,包括Src,FAK和mTOR,以及下游靶标ERK,S6激酶(S6K)和S6核糖体蛋白( S6RP)。我们测试了毛细血管内皮中S6K,S6RP和ERK磷酸化的假设,可以作为心脏同种异体移植物中抗体介导排斥(AMR)的辅助诊断工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号